Most of the time, yes, specifically for the largest net importers. In the case of China, for instance, ractopamine is an issue. It is a veterinary restriction that can be imposed on countries that use it, such as ours. Therefore, none of our products can reach that country. For the product to be certified and accepted as eligible to come into the countries is also very complex. At times, yes, this barrier may be adjusted, adapted, depending on the circumstances of supply and demand for all markets worldwide, but we've seen similar cases in Russia. We've seen changes in import declarations in the case of Japan, which is currently our largest market in terms of volume and revenue.
On April 22nd, 2013. See this statement in context.